Health Economic Assessment of Tygacil® in the Treatment of Secondary Peritonitis in Intensive Care Units (ICUs)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00481962 |
Recruitment Status
:
Completed
First Posted
: June 4, 2007
Last Update Posted
: September 28, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Peritonitis | Drug: Tygacil |
Study Type : | Observational |
Actual Enrollment : | 180 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Health Economic Assessment of Tygacil® in the Treatment of Secondary Peritonitis in Intensive Care Units |
Study Start Date : | February 2006 |
Actual Primary Completion Date : | December 2008 |
Actual Study Completion Date : | December 2008 |

-
Drug: Tygacil

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Diagnosis of secondary peritonitis
- Treatment in an ICU
- Patient age >18 years

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00481962
Germany | |
Multiple Cities, Germany |
Study Director: | Medical Monitor | Wyeth is now a wholly owned subsidiary of Pfizer | |
Principal Investigator: | Trial Manager | For Germany, medinfoDEU@wyeth.com |
Responsible Party: | Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth |
ClinicalTrials.gov Identifier: | NCT00481962 History of Changes |
Other Study ID Numbers: |
3074A1-102184 |
First Posted: | June 4, 2007 Key Record Dates |
Last Update Posted: | September 28, 2009 |
Last Verified: | September 2009 |
Additional relevant MeSH terms:
Peritonitis Intraabdominal Infections Infection Peritoneal Diseases |
Digestive System Diseases Tigecycline Anti-Bacterial Agents Anti-Infective Agents |